- Home
- AIRJ vs SMTI Comparison
AIRJ vs SMTI Comparison
Compare AIRJ & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRJ
- SMTI
- Stock Information
- Founded
- AIRJ 2018
- SMTI 1982
- Country
- AIRJ United States
- SMTI United States
- Employees
- AIRJ N/A
- SMTI N/A
- Industry
- AIRJ
- SMTI Medical/Dental Instruments
- Sector
- AIRJ
- SMTI Health Care
- Exchange
- AIRJ NYSE
- SMTI Nasdaq
- Market Cap
- AIRJ 256.6M
- SMTI 252.1M
- IPO Year
- AIRJ N/A
- SMTI N/A
- Fundamental
- Price
- AIRJ $5.65
- SMTI $29.65
- Analyst Decision
- AIRJ Strong Buy
- SMTI Strong Buy
- Analyst Count
- AIRJ 1
- SMTI 2
- Target Price
- AIRJ $12.00
- SMTI $49.50
- AVG Volume (30 Days)
- AIRJ 297.2K
- SMTI 45.1K
- Earning Date
- AIRJ 08-22-2025
- SMTI 08-11-2025
- Dividend Yield
- AIRJ N/A
- SMTI N/A
- EPS Growth
- AIRJ N/A
- SMTI N/A
- EPS
- AIRJ 0.86
- SMTI N/A
- Revenue
- AIRJ N/A
- SMTI $91,569,883.00
- Revenue This Year
- AIRJ N/A
- SMTI $23.53
- Revenue Next Year
- AIRJ N/A
- SMTI $5.93
- P/E Ratio
- AIRJ $6.37
- SMTI N/A
- Revenue Growth
- AIRJ N/A
- SMTI 34.65
- 52 Week Low
- AIRJ $3.74
- SMTI $25.86
- 52 Week High
- AIRJ $11.75
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- AIRJ 71.65
- SMTI 54.56
- Support Level
- AIRJ $4.43
- SMTI $28.00
- Resistance Level
- AIRJ $5.00
- SMTI $30.59
- Average True Range (ATR)
- AIRJ 0.38
- SMTI 1.22
- MACD
- AIRJ 0.12
- SMTI 0.27
- Stochastic Oscillator
- AIRJ 90.13
- SMTI 74.93
About AIRJ MONTANA TECHNOLOGIES CORP
AirJoule Technologies Corp is the developer of AirJoule, an atmospheric water harvesting technology that provides efficient and sustainable air dehumidification and pure water from air. AirJoule can also enable transformative HVAC products to help customers save money on their energy bills while reducing environmental impact.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.